Patent ID: 7960417

Claim:
A compound of the formula I: wherein: A is phenyl; W is selected from the group consisting of: (1) -tetrazolyl, and (2) —CO 2 H; X is selected from the group consisting of: (1) —O—, (2) —O—C 1-6 alkanediyl-, (3) —O—C 1-6 alkenediyl-, (4) —O—C 3-7 cycloalkanediyl-, and (5) —O-phenylene-, wherein the phenylene is unsubstituted or substituted with C 1-6 alkyl, or halogen; Y is —O—; Z 1 , Z 2 and Z 3 are N such that together with the fused phenyl ring they form a benzotriazolyl ring; R 1a , R 1b and R 1c may be absent if the valency at Z 1 , Z 2 or Z 3 does not permit such substitution and are independently selected from the group consisting of: (1) hydrogen, (2) C 1-6 alkyl, which is unsubstituted or substituted with a substituent selected from: (a) halogen, (b) hydroxyl, (c) phenyl, wherein the phenyl is unsubstituted or substituted with 1-5substituents independently selected from halogen, cyano, CF 3 , hydroxyl, C 1-6 alkyl, and OC 1-6 alkyl, (d) C 3-7 cycloalkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl, (e) naphthyl, which is unsubstituted or substituted with halogen, C 1-6 alkyl or phenyl, (f) —CO—C 1-6 alkyl, and (g) —COO—C 1-6 alkyl, (3) C 3-7 cycloalkyl, which is unsubstituted or substituted with halogen, C 1-6 alkyl, hydroxyl or phenyl, (4) phenyl, wherein the phenyl is unsubstituted or substituted with 1-5 substituents independently selected from halogen, hydroxyl, cyano, CF 3 , C 1-6 alkyl, and OC 1-6 alkyl, wherein the C 1-6 alkyl and OC 1-6 alkyl are linear or branched and optionally substituted with 1-5 halogen, (5) —CO—C 1-6 alkyl, and (6) —COO—C 1-6 alkyl; R 2 is selected from the group consisting of: (1) hydrogen, (2) halogen, (3) hydroxyl, (4) OC 1-6 alkyl, (5) C 2-6 alkenyl, and (6) C 1-6 alkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl; R 3a and R 3b are selected from the group consisting of: (1) hydrogen, (2) halogen, (3) C 1-6 alkyl, which is unsubstituted or substituted with halogen, hydroxyl or phenyl, and (4) OC 1-6 alkyl; R 4 may include multiple substituents and is independently selected from the group consisting of: (1) hydrogen, (2) halogen, (3) C 1-6 alkyl, and (4) —O—C 1-6 alkyl; m is an integer selected from 0, 1, 2 and 3; n is an integer selected from 0, 1, 2, 3, 4, 5 and 6; or a pharmaceutically acceptable salt thereof.